115 related articles for article (PubMed ID: 12795474)
1. Intractable hepatic encephalopathy after tips with polytetrafluoroethylene-covered stent-graft.
Riggio O; Nicolao F; Angeloni S; Masini A; Salvatori F; Fanelli F; Efrati C; Merli M
Scand J Gastroenterol; 2003 May; 38(5):570-2. PubMed ID: 12795474
[No Abstract] [Full Text] [Related]
2. Endovascular shunt reduction in the management of transjugular portosystemic shunt-induced hepatic encephalopathy: preliminary experience with reduction stents and stent-grafts.
Maleux G; Verslype C; Heye S; Wilms G; Marchal G; Nevens F
AJR Am J Roentgenol; 2007 Mar; 188(3):659-64. PubMed ID: 17312051
[TBL] [Abstract][Full Text] [Related]
3. A novel endovascular adjustable polytetrafluoroethylene-covered stent for the management of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
Weintraub JL; Mobley DG; Weiss ME; Swanson E; Kothary N
J Vasc Interv Radiol; 2007 Apr; 18(4):563-6. PubMed ID: 17446548
[TBL] [Abstract][Full Text] [Related]
4. A modified procedure for transjugular intrahepatic portosystemic shunt flow reduction.
Jacquier A; Vidal V; Monnet O; Varoquaux A; Gaubert JY; Champsaur P; Gerolami R; Bartoli JM; Moulin G
J Vasc Interv Radiol; 2006 Aug; 17(8):1359-63. PubMed ID: 16923985
[TBL] [Abstract][Full Text] [Related]
5. Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts.
Riggio O; Angeloni S; Salvatori FM; De Santis A; Cerini F; Farcomeni A; Attili AF; Merli M
Am J Gastroenterol; 2008 Nov; 103(11):2738-46. PubMed ID: 18775022
[TBL] [Abstract][Full Text] [Related]
6. Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents.
Barrio J; Ripoll C; Bañares R; Echenagusia A; Catalina MV; Camúñez F; Simó G; Santos L
Eur J Radiol; 2005 Jul; 55(1):120-4. PubMed ID: 15950109
[TBL] [Abstract][Full Text] [Related]
7. TIPS with a polytetrafluoroethylene-lined stent graft and associated haemolytic anaemia.
Fallon E; Ehrenwald E; Nazarian GK; Smith CI
Gut; 2008 Aug; 57(8):1180-1. PubMed ID: 18628385
[No Abstract] [Full Text] [Related]
8. Reversal of transjugular intrahepatic portosystemic shunt (TIPS)-induced hepatic encephalopathy using a strictured self-expanding covered stent.
Cox MW; Lin PH; Bush RL; Lumsden AB
Cardiovasc Intervent Radiol; 2003; 26(6):539-42. PubMed ID: 15061178
[TBL] [Abstract][Full Text] [Related]
9. Liver infarction following TIPS with a PTFE-covered stent: is the covering the cause?
LaBerge JM; Kerlan RK
Hepatology; 2003 Sep; 38(3):778-9; author reply 779. PubMed ID: 12939608
[No Abstract] [Full Text] [Related]
10. Management of transjugular intrahepatic portosystemic shunt induced refractory hepatic encephalopathy with the parallel technique: results of a clinical follow-up study.
Maleux G; Heye S; Verslype C; Nevens F
J Vasc Interv Radiol; 2007 Aug; 18(8):986-92; quiz 993. PubMed ID: 17675616
[TBL] [Abstract][Full Text] [Related]
11. Segmental liver ischemia after TIPS procedure using a new PTFE-covered stent.
Bureau C; Otal P; Chabbert V; Péron JM; Rousseau H; Vinel JP
Hepatology; 2002 Dec; 36(6):1554. PubMed ID: 12447885
[No Abstract] [Full Text] [Related]
12. Polytetrafluoroethylene-covered stent grafts for TIPS procedure: 1-year patency and clinical results.
Angeloni S; Merli M; Salvatori FM; De Santis A; Fanelli F; Pepino D; Attili AF; Rossi P; Riggio O
Am J Gastroenterol; 2004 Feb; 99(2):280-5. PubMed ID: 15046218
[TBL] [Abstract][Full Text] [Related]
13. Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?
Chung HH; Razavi MK; Sze DY; Frisoli JK; Kee ST; Dake MD; Hellinger JC; Kang BC
J Gastroenterol Hepatol; 2008 Jan; 23(1):95-101. PubMed ID: 18171347
[TBL] [Abstract][Full Text] [Related]
14. The use of a polytetrafluoroethylene-covered stent graft for transjugular intrahepatic portosystemic shunt (TIPS): Long-term follow-up of 100 patients.
Rössle M; Siegerstetter V; Euringer W; Olschewski M; Kromeier J; Kurz K; Langer M
Acta Radiol; 2006 Sep; 47(7):660-6. PubMed ID: 16950701
[TBL] [Abstract][Full Text] [Related]
15. TIPS-related hepatic encephalopathy: management options with novel endovascular techniques.
Madoff DC; Wallace MJ; Ahrar K; Saxon RR
Radiographics; 2004; 24(1):21-36; discussion 36-7. PubMed ID: 14730033
[TBL] [Abstract][Full Text] [Related]
16. Transjugular intrahepatic portosystemic stent-shunt: technical factors and new developments.
Tripathi D; Redhead D
Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1127-33. PubMed ID: 17033430
[TBL] [Abstract][Full Text] [Related]
17. PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome.
Hernández-Guerra M; Turnes J; Rubinstein P; Olliff S; Elias E; Bosch J; García-Pagán JC
Hepatology; 2004 Nov; 40(5):1197-202. PubMed ID: 15486923
[TBL] [Abstract][Full Text] [Related]
18. How I do it: flow-limiting stent for intractable encephalopathy following transjugular intrahepatic portosystemic shunt.
Lyon S
Australas Radiol; 2007 Dec; 51(6):564-6. PubMed ID: 17958693
[No Abstract] [Full Text] [Related]
19. Expanded PTFE-covered stent-grafts in the treatment of transjugular intrahepatic portosystemic shunt (TIPS) stenoses and occlusions.
Echenagusia M; Rodriguez-Rosales G; Simo G; Camuñez F; Bañares R; Echenagusia A
Abdom Imaging; 2005; 30(6):750-4. PubMed ID: 16245017
[TBL] [Abstract][Full Text] [Related]
20. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion: a decade of experience.
Masson S; Mardini HA; Rose JD; Record CO
QJM; 2008 Jun; 101(6):493-501. PubMed ID: 18440957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
